TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences

          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations

          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting

          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting

          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management

          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems

          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > News & Events

News & Events

PharmaLex extends footprint for technology-enabled smart services with new strategic partnership

PharmaLex extends footprint for technology-enabled smart services with new strategic partnership

7th December 2021

PharmaLex expands technology-enabled solution portfolio with integration of software platforms

PharmaLex expands technology-enabled solution portfolio with integration of software platforms

30th November 2021

We are working on webinars for 2022 . Click here to access all our past webinars

We are working on webinars for 2022 . Click here to access all our past webinars

23rd November 2021

Points de vigilance vis-à-vis de la communication institutionnelle en France

Points de vigilance vis-à-vis de la communication institutionnelle en France

23rd November 2021

Pharmalex Launches Biopharma Excellence Brand, with Ex-MHRA Scientific Lead Dr. Christian K. Schneider at the Helm

Pharmalex Launches Biopharma Excellence Brand, with Ex-MHRA Scientific Lead Dr. Christian K. Schneider at the Helm

13th October 2021

Recent changes in Australia for COVID-19 Rapid Antigen Self-Tests

Recent changes in Australia for COVID-19 Rapid Antigen Self-Tests

30th September 2021

PharmaLex with its own panel at Biotech Atelier 2021 Conference

PharmaLex with its own panel at Biotech Atelier 2021 Conference

24th September 2021

PharmaLex expands IT consulting and system integration expertise for the Life Science industry

PharmaLex expands IT consulting and system integration expertise for the Life Science industry

14th September 2021

PharmaLex participates in Inno4vac

PharmaLex participates in Inno4vac

24th August 2021

At Last Digital Transformation is Embraced by the Healthcare Industry

At Last Digital Transformation is Embraced by the Healthcare Industry

19th August 2021

PharmaLex Global Statistics and Data Science Team announced as winner by BookAuthority

PharmaLex Global Statistics and Data Science Team announced as winner by BookAuthority

16th August 2021

Data Compliance or Rejection – Are you ready for September 15th?

Data Compliance or Rejection – Are you ready for September 15th?

9th August 2021

Signal Detection

Signal Detection

16th July 2021

Log or not log (transform data) that’s the question

Log or not log (transform data) that’s the question

1st July 2021

Data Science on Blockchain with R. Part I: Reading the blockchain

Data Science on Blockchain with R. Part I: Reading the blockchain

23rd June 2021

Enoval et les laboratoires accrédités

Enoval et les laboratoires accrédités

7th June 2021

PharmaLex broadens market access and HEOR reach

PharmaLex broadens market access and HEOR reach

4th June 2021

Resilience of Pharma Supply Chains and the Impact of Covid-19 Pandemic

Resilience of Pharma Supply Chains and the Impact of Covid-19 Pandemic

17th May 2021

PharmaLex expands APAC region

PharmaLex expands APAC region

23rd April 2021

Contamination Control

Contamination Control

8th April 2021

Rules on Ownership of Medicinal Product stock distributed in Great Britain

Rules on Ownership of Medicinal Product stock distributed in Great Britain

7th April 2021

GET SMART: reliable analytical results & continuous regulatory compliance!

GET SMART: reliable analytical results & continuous regulatory compliance!

30th March 2021

PharmaLex expands France BENELUX region

PharmaLex expands France BENELUX region

16th March 2021

Challenges of Advanced Therapy Medicinal Products (ATMPs)

Challenges of Advanced Therapy Medicinal Products (ATMPs)

16th March 2021

PharmaLex broadens biopharma expertise

PharmaLex broadens biopharma expertise

5th March 2021

Supporting M&A in the pharmaceutical / biopharmaceutical industry

Supporting M&A in the pharmaceutical / biopharmaceutical industry

11th February 2021

EU GMP Annex 1

EU GMP Annex 1

25th January 2021

New Partnership Announcement for MEPHARMA and PharmaLex

New Partnership Announcement for MEPHARMA and PharmaLex

21st January 2021

BIO International Convention 2021

BIO International Convention 2021

20th January 2021

DIA RSIDM 2021

DIA RSIDM 2021

20th January 2021
Recent News
  • Quality Risk Management ICH Q9 – Revision published for public comments
    5th January 2022
  • PharmaLex extends footprint for technology-enabled smart services with new strategic partnership
    7th December 2021
  • PharmaLex expands technology-enabled solution portfolio with integration of software platforms
    30th November 2021
  • Points de vigilance vis-à-vis de la communication institutionnelle en France
    23rd November 2021
  • Proven Approaches to Accelerate Pharma Drug Development
    16th November 2021
  • TGA looks to comparable overseas regulators to speed up access to new medicines
    15th November 2021
Categories
  • All News
  • Webinars
  • Events
Archive
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
  • Statistics and Data Science
RECENT TWEETS
PharmaLexGLOBALPharmaLex@PharmaLexGLOBAL·
6 Jan

ICH releases revised Q9 guideline

The guideline makes it very clear that the protection of the patient is the primary goal of Quality Risk Management (#QRM) and we protect the patient through assurance of product quality and availability.

Read more: https://www.pharmalex.com/quality-risk-management-ich-q9-revision-published-for-public-comments/

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • I just wanted to relay our sincere thanks to you and the team for two really excellent days training. It was well organized and structured to cover regulatory expectations, GMP principle and routine work challenges of industry. The presenters and moderator were highly skilled in this area to accommodate any queries raised during the training session and were well able to keep the team engaged even in remote/virtual training session. The design of training slides was impressive and the use of technology to make virtual training was remarkable.

    Lorraine Henry
    Compliance Lead, Qualified Person, Amneal Ireland Limited
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    Click here to view our Privacy Policy.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for